fluconazole

Mycology
Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method
We evaluated the CLSI M44ed3E disk diffusion method compared with the CLSI M27ed4 broth microdilution method for caspofungin and fluconazole and the Etest method for amphotericin B to categorize susceptibility of 347 clinical isolates of Candida auris. Utilizing the zone diameter cutoffs established here, we observed overall categorical agreement between the two...

Natalie S. Nunnally, Tajah Damm, Shawn R. Lockhart, Elizabeth L. Berkow
Mycology
Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study
Meng Xiao, Zi-Yong Sun, Mei Kang, Da-Wen Guo, Kang Liao, Sharon C.-A. Chen, Fanrong Kong, Xin Fan, Jing-Wei Cheng, Xin Hou, Meng-Lan Zhou, Ying Li, Shu-Ying Yu, Jing-Jing Huang, He Wang, Ying-Chun Xu, on behalf of the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group
Mycology
In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular Genotype
Hin Siong Chong, Rebecca Dagg, Richard Malik, Sharon Chen, Dee Carter
Mycology
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
M. A. Pfaller, D. J. Diekema, D. L. Gibbs, V. A. Newell, D. Ellis, V. Tullio, A. Rodloff, W. Fu, T. A. Ling
and and the Global Antifungal Surveillance Group
Mycology
Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
M. A. Pfaller, S. A. Messer, R. J. Hollis, L. Boyken, S. Tendolkar, J. Kroeger, D. J. Diekema
Mycology
Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata
Brunella Posteraro, Rosa Martucci, Marilena La Sorda, Barbara Fiori, Dominique Sanglard, Elena De Carolis, Ada Rita Florio, Giovanni Fadda, Maurizio Sanguinetti
Mycology
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller, D. J. Diekema, D. L. Gibbs, V. A. Newell, H. Bijie, D. Dzierzanowska, N. N. Klimko, V. Letscher-Bru, M. Lisalova, K. Muehlethaler, C. Rennison, M. Zaidi
and the Global Antifungal Surveillance Group
Mycology
Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program
M. A. Pfaller, L. B. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, D. J. Diekema
Mycology
Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program
M. A. Pfaller, S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, D. J. Diekema
CASE REPORTS
Catheter-Related Fungemia Due to Fluconazole-Resistant Candida nivariensis
Shin-ichi Fujita, Yasuko Senda, Tikako Okusi, Yumi Ota, Hideaki Takada, Kazunori Yamada, Mitsuhiro Kawano

Main menu

User menu

Search

fluconazole

Pages